DiscoverThe Pharma Files
The Pharma Files
Claim Ownership

The Pharma Files

Author: The Pharma Files

Subscribed: 0Played: 2
Share

Description

The Pharma Files explores lesser-known chapters of medical history—treatments once pursued with genuine promise before evidence caught up.

Narrated by fictional investigators Lance Simard and Justine Burke, each episode examines how medical consensus forms, how it changes, and what abandoned or misunderstood therapies still reveal about modern medicine.

Where medicine meets mystery.

thepharmafiles.substack.com
7 Episodes
Reverse
In the 1930s, psychiatrists searching for answers to schizophrenia embraced a radical intervention: insulin coma therapy. By deliberately driving patients into deep hypoglycemic coma—sometimes daily for weeks—physicians believed they could “reset” the brain and disrupt psychosis. Hospitals built specialized insulin wards, and the treatment quickly became standard care despite thin evidence and significant risk. This episode explores how a dangerous shock therapy came to symbolize modern psychiatry, why dramatic case reports overshadowed missing data, and what insulin coma therapy reveals about medicine’s tendency to mistake intensity for effectiveness.For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com
In the 1920s, physician Max Gerson proposed a radical idea: cancer was not a genetic disease, but a metabolic one—driven by toxins, nutritional imbalance, and a failing liver. His therapy promised healing through strict diet, intensive juicing, supplements, and controversial coffee enemas, offering hope to patients wary of conventional treatment. This episode explores how the Gerson Therapy captured nearly a century of devotion and skepticism, why anecdote clashed with evidence, and what its persistence reveals about control, belief, and the enduring appeal of “natural” cures.For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com
In the late 1950s, thalidomide was marketed as a gentle, “safe” sedative—even for pregnant women—before it caused one of the most devastating drug tragedies in modern history. This episode explores how a lack of testing led to thousands of birth defects worldwide, why one FDA reviewer’s insistence on stronger evidence changed the course of U.S. medicine, and how thalidomide ultimately reshaped global drug regulation.For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com
In the mid-20th century, the Hoxsey Method promised a natural cure for cancer—and sparked one of the fiercest battles between alternative medicine and the medical establishment. This episode explores how an unproven herbal remedy became a national movement, why patient testimony outweighed evidence, and what the Hoxsey controversy reveals about fear, trust, and the human side of medicine. For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com
In the mid-20th century, lobotomy was hailed as a revolutionary cure for mental illness—endorsed by Nobel Prizes and embraced by overcrowded institutions desperate for solutions. This episode examines how authority, urgency, and misplaced optimism turned irreversible brain surgery into standard care, and why its quiet victims were ignored long after doubts emerged. For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com
In the 1970s, Laetrile—an apricot-pit compound rebranded as “Vitamin B17”—promised a natural cancer cure rejected by U.S. medicine. This episode explores how fear, distrust, and persuasive storytelling turned a failed treatment into a movement, long after the science said otherwise. For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com
Trailer

Trailer

2025-12-2000:55

A brief introduction to The Pharma Files, a podcast exploring overlooked chapters in medical history. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com
Comments 
loading